Cyclin‐dependent kinase inhibitor drugs as potential novel anti‐inflammatory and pro‐resolution agents

AE Leitch, C Haslett, AG Rossi - British journal of pharmacology, 2009 - Wiley Online Library
The cyclin‐dependent kinase inhibitor (CDKi) drugs such as R‐roscovitine have emerged as
potential anti‐inflammatory, pharmacological agents that can influence the resolution of …

The cyclin‐dependent kinase inhibitor R‐roscovitine down‐regulates Mcl‐1 to override pro‐inflammatory signalling and drive neutrophil apoptosis

AE Leitch, NA Riley, T A. Sheldrake… - European journal of …, 2010 - Wiley Online Library
Successful resolution of inflammation requires inflammatory cells such as neutrophils to
undergo apoptosis prior to non‐inflammatory phagocytosis by professional phagocytes …

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

AG Rossi, DA Sawatzky, A Walker, C Ward… - Nature medicine, 2006 - nature.com
Apoptosis is essential for clearance of potentially injurious inflammatory cells and
subsequent efficient resolution of inflammation. Here we report that human neutrophils …

Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis

K Wang, P Hampson, J Hazeldine, V Krystof… - PLoS …, 2012 - journals.plos.org
Neutrophils are the most abundant leukocyte and play a central role in the immune defense
against rapidly dividing bacteria. However, they are also the shortest lived cell in the blood …

Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation

AE Leitch, CD Lucas, JA Marwick, R Duffin… - Cell Death & …, 2012 - nature.com
Terminally differentiated neutrophils are short-lived but the key effector cells of the innate
immune response, and have a prominent role in the pathogenesis and propagation of many …

Roscovitine blocks leukocyte extravasation by inhibition of cyclin‐dependent kinases 5 and 9

N Berberich, B Uhl, J Joore… - British journal of …, 2011 - Wiley Online Library
BACKGROUND AND PURPOSE Roscovitine, a cyclin‐dependent kinase (CDK) inhibitor
that induces tumour cell death, is under evaluation as an anti‐cancer drug. By triggering …

[HTML][HTML] Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment

TE Lin, CR Yang, CH Chou, JY Hsu, MW Chao… - Biomedicine & …, 2022 - Elsevier
Chronic inflammation is an underlying cause in a number of diseases. Cyclin-dependent
kinase 8 (CDK8) has been implicated as an inflammatory mediator, indicating its potential as …

Modulation of granulocyte apoptosis can influence the resolution of inflammation

AG Rossi, JM Hallett, DA Sawatzky, MM Teixeira… - 2007 - portlandpress.com
Apoptosis of granulocytes and the subsequent clearance of apoptotic cells are important
processes for the successful resolution of inflammation. Signalling pathways, including …

Inflammation resolution and the induction of granulocyte apoptosis by cyclin-dependent kinase inhibitor drugs

JA Cartwright, CD Lucas, AG Rossi - Frontiers in pharmacology, 2019 - frontiersin.org
Inflammation is a necessary dynamic tissue response to injury or infection and it's resolution
is essential to return tissue homeostasis and function. Defective or dysregulated …

The cyclin dependent kinase inhibitor (R)-roscovitine prevents alloreactive T cell clonal expansion and protects against acute GvHD

L Li, H Wang, JS Kim, G Pihan, VA Boussiotis - Cell Cycle, 2009 - Taylor & Francis
Cell cycle re-entry of quiescent T lymphocytes regulated by cdk2 is required for antigen-
specific clonal expansion and generation of productive T cell responses. Recently, we …